Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Idor-1117-2520
2. 2737274-49-4
3. Orb2565979
4. Schembl26105827
5. Schembl30281923
6. Ex-a9084
7. Hy-162495
8. Cs-1053576
9. H61601
10. 2-[3-[5-[(r)-(1,3-dimethylazetidin-3-yl)-hydroxy-(4-propan-2-ylphenyl)methyl]pyridin-3-yl]-1,2,4-oxadiazol-5-yl]propan-2-ol
| Molecular Weight | 436.5 g/mol |
|---|---|
| Molecular Formula | C25H32N4O3 |
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 6 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 95.5 |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 645 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
16
PharmaCompass offers a list of IDOR-1117-2520 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right IDOR-1117-2520 manufacturer or IDOR-1117-2520 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred IDOR-1117-2520 manufacturer or IDOR-1117-2520 supplier.
A IDOR-1117-2520 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of IDOR-1117-2520, including repackagers and relabelers. The FDA regulates IDOR-1117-2520 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. IDOR-1117-2520 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A IDOR-1117-2520 supplier is an individual or a company that provides IDOR-1117-2520 active pharmaceutical ingredient (API) or IDOR-1117-2520 finished formulations upon request. The IDOR-1117-2520 suppliers may include IDOR-1117-2520 API manufacturers, exporters, distributors and traders.
IDOR-1117-2520 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of IDOR-1117-2520 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right IDOR-1117-2520 GMP manufacturer or IDOR-1117-2520 GMP API supplier for your needs.
A IDOR-1117-2520 CoA (Certificate of Analysis) is a formal document that attests to IDOR-1117-2520's compliance with IDOR-1117-2520 specifications and serves as a tool for batch-level quality control.
IDOR-1117-2520 CoA mostly includes findings from lab analyses of a specific batch. For each IDOR-1117-2520 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
IDOR-1117-2520 may be tested according to a variety of international standards, such as European Pharmacopoeia (IDOR-1117-2520 EP), IDOR-1117-2520 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (IDOR-1117-2520 USP).
